For example, the anti-CRC effects of compounds such as EGCG, TRAIL, DHA plus TRAIL, and nsPEF treatment have been attributed in part to caspase activity, particularly caspase 3/7 [17, 24, 39, 50]. Here, CASP3 is linked to colorectal carcinoma.